CD8A and neoplasm: While treatment with VZV-vax alone led to a modest increase in E7-specific CD8+ T cells measured by dextramer staining (Fig. 6E), these responses where further increased when VZV-vax was admixed with the tumor-specific E744-62 peptide (Fig. 6E).